Last month Walmart organized a “summit” conference in Orlando, Fla., to explore the opportunities in bringing more consumer-goods manufacturing back to the United States. The carrot was, of course, Walmart’s commitment to buy — and sell — more goods made in America, at the expense of foreign-produced products.
The drive toward coordinated health care is redefining the relationships between providers and creating opportunities for drug chains and other community pharmacy operators to become more tightly woven into the continuum of care. The momentum behind the transition continues to build, with two programs unveiled in recent weeks illustrating the trend.
America is a nation in pain. Over 100 million Americans suffer from chronic pain, and the annual cost of health care for pain (including disability days and lost wages and productivity) is estimated at between $560 billion and $635 billion. Consequently, it’s not surprising that 33 million Americans rely on regular use of ingestible nonsteroidal anti-inflammatory drugs (NSAIDs) to manage their pain symptoms.